Transaction · 0001193125-26-037644

Invus Global Management, LLC

Invus Global Management, LLC, DIR, reported a transaction classified as grant at LEXICON PHARMACEUTICALS, INC. involving 3846154.000000 shares for an estimated $5000000.20. Reported holdings after the transaction were 7362368.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
LXRXLEXICON PHARMACEUTICALS, INC.
Filing timeFeb 04
Trade dateFeb 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$1.27
Pre-filing
1mo ago -11.0%1w ago +23.6%1d ago -9.4%
Returns since
7d +7.9%30d +34.6%90d +29.9%180d +83.5%1y +80.3%

LXRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
LXRX since 2026-02-04Filed 211 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001193125-26-037644
Common Stock
Transaction date
Feb 02, 2026
Filed Feb 04, 2026, 09:25 PM · 2d delay
Shares
3.84M sh
$130 per share
Estimated value
$500M
Computed from shares × price
Holdings after
7.36M sh
Indirect · See Footnotes

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Large Holdings Increase
-18score
Filing-only score

-18

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    On January 29, 2026, Artal Participations S.a r.l. entered into a purchase agreement with the Issuer pursuant to which Artal Participations S.a r.l. agreed to purchase 22,400,000 shares of common stoc…

  2. F2

    On February 2, 2026, Avicenna Life Sci Master Fund LP purchased 1,538,462 shares of Common Stock as part of the Issuer's underwritten public offering.

  3. F3

    On January 29, 2026, Artal Participations S.a r.l. entered into a preferred stock purchase agreement (the "Preferred Purchase Agreement") with the Issuer pursuant to which Artal Participations S.a r.l…

  4. F4

    These securities are directly held by Artal Participations S.a r.l.

  5. F5

    These securities are directly held by Invus Public Equities, L.P.

  6. F6

    These securities are directly held by Avicenna Life Sci Master Fund LP

  7. F7

    These securities are directly held by Invus, L.P.

  8. F8

    These securities are directly held by Invus US Partners LLC

  9. F9

    The sole shareholder of Artal Participations S.a r.l. is Artal International S.C.A. The managing partner of Artal International S.C.A. is Artal International Management S.A. The sole stockholder of Ar…

  10. F10

    The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The managing member of Invus Public Equities Advisors, LLC is Invus Global Management, LLC. The managing memb…

  11. F11

    The general partner of Avicenna Life Sci Master Fund LP is Avicenna Life Sci Master GP LLC. The managing member of Avicenna Life Sci Master GP LLC is Ulys, L.L.C. The managing member of Ulys, L.L.C. i…

  12. F12

    The general partner of Invus, L.P. is Invus Advisors, L.L.C. The managing member of Invus Advisors, L.L.C. is Invus Global Management, LLC. The managing member of Invus Global Management, LLC. is Sire…

  13. F13

    The managing member of Invus US Partners LLC is Ulys, L.L.C. The managing member of Ulys, L.L.C. is Mr. Raymond Debbane.

  14. F14

    These securities are directly held by Mr. Raymond Debbane.

  15. F15

    Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to th…

Original filing · 0001193125-26-037644
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

LXRX